J David Smeijer

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Atrial Fibrillation

Acute Heart Failure

Top Venues

Diabetes, obesity & metabolism

Journal of the American Society of Nephrology : JASN

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

J David Smeijer, Victor S Wasehuus, Neeraj Dhaun, Jose Luis Gorriz Teruel, Maria José Soler, Magnus Åstrand, Anne-Kristina Mercier, Peter J Greasley, Philip Ambery, Hiddo J Lambers Heerspink
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD. Journal of the American Society of Nephrology : JASN (2024)
J David Smeijer, Donald E Kohan, Dick de Zeeuw, Hiddo J Lambers Heerspink
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan. Diabetes, obesity & metabolism (2023)
J David Smeijer, Donald E Kohan, D de Zeeuw, Hiddo J Lambers Heerspink
Diuretic medication and change in fluid retention biomarkers during treatment with the endothelin receptor antagonist atrasentan. Diabetes, obesity & metabolism (2023)
J David Smeijer, Jeroen V Koomen, Donald E Kohan, John J V McMurray, George L Bakris, Ricardo Correa-Rotter, Fan Fan Hou, Dalane W Kitzman, Hirofumi Makino, Gert Mayer, Michal Nowicki, Vlado Perkovic, Peter Rossing, Sheldon Tobe, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J L Heerspink
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney Disease. Clinical pharmacology and therapeutics 112 (5) (2022)